In addition, TRIM17 acts as a negative regulator of the apoptotic reaction and is triggered by cancer treatments; Knockdown of TRIM17 was observed to improve the efficacy of chemotherapy, demonstrating therapeutic potential in gastric cancer (39). This evidence concerns the gene TRIM17 and gastric cancer.